Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Basic Clin Pharmacol Toxicol ; 96(2): 111-7, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15679473

RESUMO

The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime (24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals (10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the following order: monocrotophos > heptenophos > dichlorvos. Administration of the oxime produced a significant reactivation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of monocrotophos-inhibited acetylcholinesterase in any of the tissues tested. These organophosphorus compounds produced a significant inhibition of plasma carboxylesterase activity, while administration of trimedoxime led to regeneration of the enzyme activity. The same dose of trimedoxime assured survival of experimental animals poisoned by all three organophosphorus compounds, although the biochemical findings were quite different.


Assuntos
Diclorvós/intoxicação , Monocrotofós/intoxicação , Intoxicação por Organofosfatos , Trimedoxima/uso terapêutico , Acetilcolina/química , Acetilcolina/metabolismo , Animais , Química Encefálica/efeitos dos fármacos , Carboxilesterase/antagonistas & inibidores , Carboxilesterase/sangue , Carboxilesterase/efeitos dos fármacos , Diafragma/efeitos dos fármacos , Diafragma/fisiologia , Diclorvós/administração & dosagem , Diclorvós/antagonistas & inibidores , Avaliação Pré-Clínica de Medicamentos/métodos , Eritrócitos/química , Eritrócitos/efeitos dos fármacos , Eritrócitos/fisiologia , Injeções Intravenosas , Dose Letal Mediana , Masculino , Camundongos , Monocrotofós/administração & dosagem , Monocrotofós/antagonistas & inibidores , Compostos Organofosforados/administração & dosagem , Compostos Organofosforados/antagonistas & inibidores , Oximas/administração & dosagem , Oximas/farmacologia , Oximas/uso terapêutico , Fatores de Tempo , Trimedoxima/administração & dosagem , Trimedoxima/farmacocinética
2.
Eksp Klin Farmakol ; 62(5): 35-7, 1999.
Artigo em Russo | MEDLINE | ID: mdl-10572750

RESUMO

Experiments on Wistar rats and noninbred mice showed that dipyroxim (10 mg/kg administered 3 times per 24 h) and thymogen (10 mg/kg daily for 3 days) restore the reduced under the effect of acute dichlorethane poisoning in a dose of 0.75 LD50 the organism's anti-infectious unspecific resistance and the main humoral and cell immune reactions. Summing of the effects of the drugs under study was encountered in the case of the T-dependent humoral immune response. The effect of dipyroxim was due to restoration of alpha-naphthyl-AS-acetatesterase of immunocytes and, possibly, other types of esterases of T-cells, macrophages, and monocytes.


Assuntos
Dipeptídeos , Dicloretos de Etileno/intoxicação , Homeostase/efeitos dos fármacos , Doença Aguda , Adjuvantes Imunológicos/administração & dosagem , Animais , Formação de Anticorpos/efeitos dos fármacos , Antídotos/administração & dosagem , Reativadores da Colinesterase/administração & dosagem , Avaliação Pré-Clínica de Medicamentos , Homeostase/imunologia , Imunidade Celular/efeitos dos fármacos , Imunidade Inata/efeitos dos fármacos , Camundongos , Peptídeos/administração & dosagem , Intoxicação/tratamento farmacológico , Intoxicação/imunologia , Ratos , Ratos Wistar , Fatores de Tempo , Trimedoxima/administração & dosagem
3.
Mil Med ; 164(1): 55-8, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9922646

RESUMO

The degradation of trimedoxime in concentrated (114 mg/ml) acidic solutions was studied at several temperatures in the pH range 3.0 to 4.3. The degradation profile showed a relationship indicative of first-order kinetics. Trimedoxime was found to be stable in the pH range 3.0 to 3.8, with maximum stability at pH 3.0. The activation energy of the hydrolysis reaction at pH 3.0 was found to be 19.4 kcal/mol, and the half-life was 124 years. General equations were derived relating the half-life of trimedoxime solution to pH and temperature. The t90 value at 25 degrees C was calculated for each pH value studied and was found to be 11 to 18 years within the pH range 3.0 to 3.8.


Assuntos
Antídotos/metabolismo , Reativadores da Colinesterase/metabolismo , Trimedoxima/metabolismo , Antídotos/administração & dosagem , Reativadores da Colinesterase/administração & dosagem , Avaliação Pré-Clínica de Medicamentos , Estabilidade de Medicamentos , Humanos , Concentração de Íons de Hidrogênio , Hidrólise , Injeções Intramusculares , Soluções , Temperatura , Fatores de Tempo , Trimedoxima/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA